NAUTNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Nautilus Biotechnology, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026
$2.63+0.57 (+27.67%)
Close on Oct 19, 2026
- Market cap
- $334.37M
- P/E (TTM)
- –
- Dividend yield
- –
Fundamental chart
Pick a measure to chart its full history
-$59.00MFY2025